ImmuPharma PLC is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The company's portfolio includes novel peptide therapeutics for autoimmune diseases and anti-infectives. ImmuPharma's lead program,...
Synairgen PLC is a UK-based respiratory company focused on drug discovery, development and commercialisation. The company's primary focus is developing SNG001 (inhaled interferon beta) for the treatment of severe viral lung infections as...
Join our audience of astute high net worth investors, fund managers, private client brokers and analysts
Look beyond the numbers and meet the people creating the value for shareholders
Each company has a presentation slot followed by Q & A, giving you the chance to discover the real story
Watch the event afterwards on our YouTube channel